Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT04033497
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MRI — DEVICEMagnetic Resonance Imaging will generate imaging of the brain to identify recurrence of tumor.
Study Details
This research study is investigating the value of an imaging study of the brain called an MRI (which stands for magnetic resonance imaging), utilized in unique way, to delineate whether the tumor has recurred or whether radiation changes have occurred after a brain metastasis treated with focused radiation has enlarged.
Key Dates
- Start date
- Aug 20, 2019
- Status verified
- Mar 2026
- Primary completion
- Jul 1, 2027
- Completion
- Jul 1, 2028
Study Design
- Enrollment
- 101 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: TRAMs I* Magnetic resonance imaging (MRI)-based treatment response assessment maps (TRAMs) * Patients with an enlarging lesion in the site of a brain metastasis treated with stereotactic radiation for which neurosurgical resection is planned will undergo preoperative TRAMs
Primary Outcome Measure
Sensitivity [ Time Frame: Within 3 months of study enrollment ]
Central Contacts
- Ayal Aizer, MD, MHS617-732-7560
- Ivy Ricca, BA6175828927
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | Ayal A Aizer, MD, MHS (PRINCIPAL_INVESTIGATOR) |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | Ayal Aizer, MD, MHS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
By condition
By specialty
Related Studies
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California
- Local Control, Quality of Life and Toxicities in Adults With Benign or Indolent Brain Tumors Undergoing Proton Radiation TherapyRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)Recruiting · GT Medical Technologies, Inc. · Phoenix, Arizona
- A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated GlioblastomaPHASE3 · Recruiting · Ivy Brain Tumor Center · Birmingham, Alabama